Over the past few days, medtech's biggest names gathered in San Francisco for the Transcatheter Cardiovascular Therapies (TCT ...

Emerging cardiovascular technology, trends in ambulatory care, provider and payer partnerships, and value-based arrangements create strategic opportunities to address service demand and cost pressures ...

Please provide your email address to receive an email when new articles are posted on . The European and UK markets will have access to the CLAiR technology from Toku. CLAiR assesses cardiovascular ...

Here, five cardiology leaders weigh in on the possibilities of ending cardiovascular disease: Gopi Dandamudi, MD. Executive Medical Director of the Center for Cardiovascular Health at Virginia Mason ...

As digital health technologies gain momentum, research is finding that more people are open to artificial intelligence (AI) supported health interventions when those are backed by clinical expertise ...

One person dies of cardiovascular disease (CVD) every 34 seconds in the U.S., making it the nation’s leading cause of death. This chronic condition affects roughly 127.9 million Americans, and from ...

Novo Nordisk’s oral therapy Wegovy (semaglutide) reduced cardiovascular risk factors in the Phase III OASIS 4 trial. Being ...

Modern cardiovascular care involves human acumen, complex data and collaborative intelligence between the two. Payment models are based on well-defined tests and procedures and are baffled by the ...

Major Insurer Joins UnitedHealthcare in Covering Cleerly's AI-QCT/AI-CPA Technology, Expanding Access to 61 Million Americans Cleerly, a leader in AI-based cardiovascular imaging, today announced that ...

(AP) - Johnson & Johnson is spending more than $16 billion to move deeper into treating heart disease and continue a shift started last year away from its consumer health roots. The health care giant ...